✦ LIBER ✦

P042 - 2 year follow up of adalimumab therapy in patients with Crohn's disease

✍ Scribed by K. Kemp; M. Dibb; A.J. Makin; S. Campbell

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adalimumab for recurrent orbital myositi

✍ María-Luisa Hernández-Garfella; Alicia Gracia-García; Enrique Cervera-Taulet; Ca 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 292 KB

P173 - Efficacy of adalimumab in patient

✍ P. Cordero Ruiz; C. Catro Marquez; V. Mendez Rufian; L. Castro-Laria; á. Caunedo 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 46 KB

P078 ADALIMUMAB SUSTAINS QUALITY-OF-LIFE

✍ E.V. Loftus Jr; J.F. Colombel; R. Panaccione; B.G. Feagan; P.F. Pollack; J. Chao 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 90 KB

P006 ADALIMUMAB MAINTAINS LONG-TERM REMI

✍ R. Panaccione; W.J. Sandborn; G.R. D'Haens; R. Enns; D.C. Wolf; K.G. Lomax; P.F. 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 92 KB

M1090 Infliximab Therapy Significantly R

✍ Sprakes, Michael B.; Ford, Alexander C.; Lisa, Warren; Greer, Dan; Jennings, Jas 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 183 KB

P117 - Global safety of adalimumab in tr

✍ J.F. Colombel; R. Panaccione; W.J. Sandborn; P. Rutgeerts; S.B. Hanauer; W. Rein 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 51 KB